In the T2D study, correlations of VMAT2 density, a biomarker of BCM, correlated with years of T2D diagnosis, glycemic control, and beta-cell functional measures, suggesting that PET was able to quantify changes in BCM (3). Here, SLC18A2 is linked to type 2 diabetes mellitus.